The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 15, 2015
Filed:
Jun. 09, 2014
Applicant:
Gilead Connecticut, Inc., Foster City, CA (US);
Inventors:
Scott A. Mitchell, East Haven, CT (US);
Kevin S. Currie, North Branford, CT (US);
Assignee:
GILEAD CONNECTICUT, INC., Foster City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); A61K 31/495 (2006.01); C07D 519/00 (2006.01); C12Q 1/48 (2006.01); C07D 471/04 (2006.01); C07D 491/107 (2006.01); G01N 33/573 (2006.01);
U.S. Cl.
CPC ...
C07D 498/04 (2013.01); A61K 31/495 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/107 (2013.01); C07D 519/00 (2013.01); C12Q 1/485 (2013.01); G01N 33/573 (2013.01);
Abstract
Provided are imidazopyrazine compounds, particularly including 6-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a]pyrazine-8-amine, structure below, and methods and formulations for their use in inhibiting Spleen Tyrosine Kinase in treating conditions including B-cell lymphomas or leukemias and inflammatory conditions: